Source MDx - Product Pipeline Analysis

Date: October 1, 2011
Pages: 27
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S6B690655EAEN
Leaflet:

Download PDF Leaflet

Source MDx - Product Pipeline Analysis
Source MDx - Product Pipeline Analysis

Summary

Source MDx (Source) is a privately held medical device company. It is principally engaged in the development of RNA-based biomarkers and companion diagnostics. The company develops its products in inflammation related therapeutic areas including oncology, cardiovascular, autoimmune and infectious diseases for pharmaceutical and biotech companies. It developed an integrated molecular diagnostic system that consists of three core elements including precision profiles, normal reference ranges and sophisticated statistical approaches to measure the vital signs of the cell.

This report is a source for data, analysis and actionable intelligence on the Source MDx portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.
Key Facts
Source MDx - Major Products and Services
Source MDx Pipeline Products by Equipment Type
Source MDx Pipeline Products by Development Stage
Aggressive Cancer Stratification – Prostate Cancer
Product Status
Product Description
Product Patent Details
Precision Profile - Immunosuppression
Product Status
Product Description
Product Patent Details
Precision Profile - Pancreatic Cancer
Product Status
Product Description
Product Patent Details
Precision Profile - Systemic Inflammatory Respiratory Disease
Product Status
Product Description
Product Patent Details
Source MDx - Key Competitors
Source MDx - Key Employees
Source MDx - Locations And Subsidiaries
Head Office
Recent Developments
Mar 22, 2011: Source MDx To Offer Foundational Patents For Sale On April 29, 2011
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Source MDx, Key Facts
Source MDx Key Pipeline Products by Equipment Type
Source MDx Key Pipeline Products by Development Stage
Source MDx, Key Facts
Source MDx, Major Products and Services
Source MDx Number of Pipeline Products by Equipment Type
Source MDx Pipeline Products by Equipment Type
Source MDx Number of Pipeline Products by Development Stage
Source MDx Pipeline Products by Development Stage
Aggressive Cancer Stratification – Prostate Cancer - Product Status
Aggressive Cancer Stratification – Prostate Cancer - Product Description
Aggressive Cancer Stratification – Prostate Cancer - Patent Details
Precision Profile - Immunosuppression - Product Status
Precision Profile - Immunosuppression - Product Description
Precision Profile - Immunosuppression - Patent Details
Precision Profile - Pancreatic Cancer - Product Status
Precision Profile - Pancreatic Cancer - Product Description
Precision Profile - Pancreatic Cancer - Patent Details
Precision Profile - Systemic Inflammatory Respiratory Disease - Product Status
Precision Profile - Systemic Inflammatory Respiratory Disease - Product Description
Precision Profile - Systemic Inflammatory Respiratory Disease - Patent Details
Source MDx, Key Employees

LIST OF FIGURES

Source MDx Key Pipeline Products by Equipment Type
Source MDx Pipeline Products by Equipment Type
Source MDx Pipeline Products by Development Stage

COMPANIES MENTIONED

BioDtech, Inc.
Pathogenetix, Inc.
Precision Therapeutics, Inc.
Atherotech, Inc.
HemaTechnologies, Inc.
BioE Corporation
ForteBio, Inc.
Chronix Biomedical, Inc.
AbaStar MDx - Product Pipeline Analysis US$ 750.00 Oct, 2011 · 16 pages
Seegene, Inc. - Product Pipeline Analysis US$ 750.00 Oct, 2011 · 59 pages
Renishaw plc (RSW) - Product Pipeline Analysis US$ 750.00 Sep, 2011 · 22 pages

Ask Your Question

Source MDx - Product Pipeline Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: